Welcome to the CRISPR Powerhouse – the power & flexibility of CRISPR/Cas9 for the antibody manufacturing pipeline.
In The Medicine Maker, ERS Genomics CEO, Eric Rhodes explores the power and flexibility of CRISPR/Cas9 for the antibody manufacturing pipeline, including for next-generation antibody-drug…